Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +239498919813.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Capital expenditure changed +7998.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Operating margin changed -4708 basis points from the comparable as-filed period.
Gross margin changed -998 basis points from the comparable as-filed period.
Research & development changed +630.6% from the comparable as-filed period.
Shares outstanding changed +160.3% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
Cash & equivalents changed +873.7% from the comparable as-filed period.
SBC / revenue changed +8184 basis points from the comparable as-filed period.
Current assets changed +1660.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Operating income changed -1661.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Capex / revenue changed +774 basis points from the comparable as-filed period.
Inventory / revenue changed -11627 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.